News Digging > Featured > High Response Rate to Pembrolizumab in Unresectable Desmoplastic Melanoma Trial
High Response Rate to Pembrolizumab in Unresectable Desmoplastic Melanoma Trial
High Response Rate to Pembrolizumab in Unresectable Desmoplastic Melanoma Trial,Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after

High Response Rate to Pembrolizumab in Unresectable Desmoplastic Melanoma Trial

Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after